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Abstract Mg-F-actin occurs in two conformational states, I
and M, where the N-terminal amino acids are either immobile or
highly mobile. In the rigor or ADP complex of rabbit myosin S1
with Mg-F-actin the N-terminal acetyl group of actin stays in its
highly mobile state. The same is true for the complexes with the
myosin motor domain from Dictyostelium discoideum. This
excludes a direct strong interaction of the N-terminal amino
acids with myosin in the rigor state as suggested. An interaction
of the N-terminus of F-actin with myosin is also not promoted
by occupying its low-affinity binding site(s) with divalent ions.
The N-terminal high-mobility region may be part of a structural
system which has evolved for releasing inadequate stress applied
to the actin filaments ' 2002 Published by Elsevier Science
B.V. on behalf of the Federation of European Biochemical So-
cieties.
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1. Introduction
Actin and myosin represent the main components of the
contractile system in eukaryotes. Actin ¢laments (F-actin)
can be formed by polymerizing monomeric actin (G-actin)
by addition of KCl in moderate concentrations (v 30 mM).
Actin binds one adenine nucleotide molecule and one divalent
metal ion per protomer at its high-a⁄nity binding site. When
it contains a Mg2þ ion at its high-a⁄nity site (as is expected
under in vivo conditions) F-actin occurs in two di¡erent con-
formational states, the M state where the N-terminal amino
acids are highly mobile and the I state where they are immo-
bilized [1,2]. The X-ray structure of rabbit G-actin has been
determined in complex with DNase I [3], with segment 1 of
gelsolin [4], in complex with pro¢lin [5], and uncomplexed in
the ADP state [6]. Starting with the X-ray structure of G-actin
the atomic structure of F-actin has been solved using X-ray
small angle scattering [7,8]. The obtained structure is consis-
tent with most of the extensive biochemical, spectroscopic and
electron microscopic data (for a review see [9^11]).
Myosin forms a still expanding family of motor proteins
which are able to produce a unidirectional movement of actin
¢laments under simultaneous hydrolysis of ATP. The crystal-
lization of subfragment S1 from skeletal muscle myosin [12],
the myosin motor domain from Dictyostelium discoideum [13^
15], smooth muscle myosin [16] and scallop S1 [17] with di¡er-
ent nucleotides and nucleotide analogs gives detailed structur-
al models which can be related to di¡erent functional states.
However, some parts of the structure assumed to be mobile or
disordered as the N-terminal parts of the light chains are
missing in the electron density maps. Myosins of D. discoi-
deum have the big advantage that they are easily available to
modern techniques of molecular biology.
From the existing structures of F-actin and myosin the
structure of the actomyosin complex in di¡erent functional
states has been modelled on the basis of X-ray small angle
scattering or electron microscopic data [18^20].
Nuclear magnetic resonance (NMR) spectroscopy is com-
plementary to X-ray crystallography especially since it shows
highly mobile regions of biological macromolecules which are
usually not visible in the X-ray crystallography. In the past a
large number of NMR studies of the actomyosin system have
been published [1,2,21^39]. In rabbit skeletal muscle myosin
S1 (A1) the signals of the N-terminal N-trimethyl-alanine res-
idue of the essential light chain LC1 can be observed by 1H
NMR spectroscopy, which are quenched after binding of my-
osin S1 to F-actin. This suggests that the N-terminus of LC1
binds to F-actin [32,39^41]. Cross-linking studies support the
notion of a direct interaction in the C-terminal region near
Glu-361 to Glu-364 [42^44]. Cross-linking indicates that the
interaction of LC1 with actin does not involve the same pro-
tomer as that of the corresponding heavy chain [45].
2. Materials and methods
2.1. Protein preparation
Actin from rabbit skeletal muscle was prepared from acetone pow-
der as described by Pardee and Spudich [46] modi¢ed according to
Heintz et al. [2]. Rabbit myosin S1 was prepared according to Weeds
and Taylor [47]. Clone M754 encoding amino acids 1^754 of the
motor domain of myosin II from D. discoideum was used [48]. At
its C-terminus it contains the non-myosin sequence LARILGSTR-
DALHHHHHHHH. It was expressed in D. discoideum and puri¢ed
as described by Manstein and Hunt [48].
2.2. Sample preparation
For 1H NMR experiments the sample was usually dissolved in
bu¡er B (0.2 mM ATP, 0.1 mM MgCl2, 0.2 mM EGTA, 1 mM
NaN3, 2 mM Tris^HCl, pH 7.8, 90% H2O/D2O 10%). Polymerization
of actin was induced by adding appropriate quantities of a stock so-
lution of 3 M KCl to obtain a ¢nal concentration of 30 mM. As
internal reference 0.1 mM 3-(trimethylsilyl)-tetradeutero propionic
acid (TSP) was added.
2.3. NMR measurements
NMR spectra were measured on Bruker DRX-500, DRX-600 and
DMX-800 spectrometers operating at proton frequencies of 500 MHz,
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600 MHz and 800 MHz, respectively. In one-dimensional 1H NMR
spectroscopy the water signal was usually suppressed by selective pre-
saturation. Typically, 512 free induction decays were accumulated
with a repetition time of 5 s including the water suppression pulse
of 1 s.
2.4. NMR data processing and software
Data were processed with the XWINMR package (Bruker) running
on a Silicon Graphics Indigo2 workstation.
3. Results
3.1. Interaction of F-actin with rabbit skeletal muscle myosin
Titration of Mg-F-actin with myosin or myosin S1 should
lead to the disappearance of signals of the N-terminal residues
of actin if they are involved in a direct interaction with my-
osin. Fig. 1A shows the results. For establishing a pure rigor
state alkaline phosphatase was added which hydrolyzes the
nucleotides completely. When the actin concentration is held
constant and the myosin concentration is increased, the signal
intensity of the N-acetyl signal of F-actin remains unchanged.
Slightly down¢eld shifted from the signal of the N-acetyl
group a new singlet resonance appears at 2.050 ppm when
the S1 concentration is increased. This resonance has been
assigned earlier to the N-acetyl group of myosin light chain
LC3 [40] which is also contained in our S1 preparation in low
concentration. The myosin LC3 is also not in£uenced by bind-
ing to actin.
Fig. 1. 1H NMR spectra of rabbit myosin S1 and Mg-F-actin. Spec-
tra were recorded at 800 MHz at 288 K. A: Upper trace: The sam-
ple contained 29 WM actin in bu¡er A consisting of 2 mM Tris^
HCl, pH 7.8, 30 mM KCl, 22 WM phalloidin, 1 U/ml alkaline phos-
phatase, 0.2 mM ATP, 0.1 mM MgCl2, 0.2 mM EGTA, 1 mM
NaN3, in 90% H2O, 10% D2O. Alkaline phosphatase was added ap-
proximately 10 min after polymerizing actin by addition of KCl.
The sample contained in addition 13 WM myosin S1 (middle trace)
or 22 WM myosin S1 (lower trace). B: Upper trace: The sample
contained 31 WM myosin S1 in bu¡er A. The sample additionally
contained 19 WM actin (middle trace) or 27 WM myosin S1 (lower
trace). The star indicates low-molecular-mass impurities, all NMR
spectra were recorded under identical experimental conditions.
Fig. 2. 1H NMR spectra of the myosin motor domain of D. discoi-
deum and Mg-F-actin. Spectra were recorded under identical condi-
tions and were contained in the same bu¡er as described in Fig. 4
for rabbit myosin. The sample contained 17 WM myosin motor do-
main of D. discoideum and actin in various concentrations; actin
concentrations from top to bottom 0 WM actin, 6.3 WM, 25.2 WM,
and 21.5 WM. The star indicates low-molecular-mass impurities, all
NMR spectra were recorded under identical experimental condi-
tions.
Fig. 3. E¡ect of ATP and/or vanadate on the 1H NMR spectra of
actin and myosin. Spectra were recorded at 800 MHz at 288 K.
The samples contained 32 WM rabbit myosin S1 in 2 mM Tris^HCl,
pH 7.8, 30 mM KCl, 40 WM phalloidin, 0.1 mM MgCl2, 0.2 mM
EGTA, 1 mM NaN3, in 90% H2O, 10% D2O. In addition sample a
contained 0.2 mM ATP, sample b 40 WM actin, 4 mM ATP and
1 mM Na3VO4, sample c 40 WM actin and 4 mM ATP and
sample d 40 WM actin and 2 mM ADP. The star indicates low-mo-
lecular-mass impurities, all NMR spectra were recorded under iden-
tical experimental conditions.
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In another set of experiments (Fig. 1B) the myosin concen-
tration was held constant but the concentration of actin was
varied. In these experiments the changes in the myosin reso-
nances induced by binding of actin can be easily observed.
The N-terminal amino acid sequence of myosin LC1 starts
with (CH3)3Nþ-Ala-Pro-Lys-Lys-Asp-Val- and contains 12
alanine residues in its ¢rst 31 N-terminal residues. The signals
of the trimethylamino group give rise to a strong singlet res-
onance at 3.25 ppm, the signals of the alanine L-methyl
groups are expected at 1.37 ppm [39]. The signals of the tri-
methylamino group (Fig. 4) and of the L-methyl group of
mobile alanine residues of LC1 are quenched by binding of
myosin indicating that they are immobilized or strongly ex-
change broadened with binding to actin. A quantitation of the
signals around 1.37 ppm disappearing after binding would
lead to a signal reduction that corresponds to approximately
20 methyl groups. This rather large number indicates that this
signal is composed also of resonances of residues other than
alanines but would be in line with the proposition that a large
part of the N-terminus of LC1 gets immobilized. In addition,
a number of other resonances are quenched with actin bind-
ing, e.g. the signal at 0.81 ppm, the broad signals at 1.46 and
1.69 ppm. In contrast, the signal from the N-terminal acetyl
group of myosin LC3 (2.05 ppm) is clearly not in£uenced by
actin binding. This is also true for the narrow singlet reso-
nances at 2.06 and 2.11 ppm which originate from the methyl
groups of two (not yet assigned) methionine residues of my-
osin.
3.2. Interaction of actin with the motor domain of myosin from
D. discoideum
The motor domain of D. discoideum exhibits a spectrum
typical for a well-folded protein (Fig. 2). Since it contains
no light chains, the sharp signals arising from the light chains
bound in myosin S1 cannot be present. Nevertheless, the spec-
trum contains two sharp singlet resonances at 2.05 and 2.09
ppm which present either methyl groups of methionines or an
N-acetyl group (Fig. 2).
With increasing actin concentrations all signals from the
motor domain are quenched. This is also true for the signal
at 2.05 ppm which overlaps with the N-acetyl signal from
F-actin. Only about 50% of the protomers of Mg-F-actin
are in the M state, which means that the relative intensity
of the N-acetyl signal from F-actin should have half the in-
tensity of the methyl signal of the motor domain. Assuming
that the myosin signal is quenched after binding but the F-ac-
tin signal is not in£uenced as in rabbit S1, the signal intensity
should ¢rst decrease, have a minimum when the actin to my-
osin ratio is 1, and then should increase with increasing actin
concentrations. Just such a behavior is observed in Fig. 2.
This means that also the motor domain of D. discoideum
does not interact with the N-acetyl of F-actin.
3.3. Actomyosin interaction in the presence of ATP and/or
vanadate
Myosin with ATP bound at the active center should inter-
act with F-actin only weakly. The addition of ATP to acto-
myosin leads to no signi¢cant spectral changes when com-
pared with the rigor state (Fig. 3). Especially, the
trimethylamino signal of LC1 does not recover. Vanadate
binds to myosin.ADP and is assumed to form a transition
state similar to the ADP.Pi state of myosin. Fig. 3 shows
the result of adding vanadate to actomyosin, the spectral
changes observed indicate that some of the myosin bound is
released since signals typical for free myosin reappear. This
can be best seen when observing the trimethylamino signal
from myosin (Fig. 4). This signal is quenched completely in
the rigor state but reappears partly after addition of vanadate.
However, even after prolonged incubation with vanadate only
about 20% of the signal intensity reappears indicating that
under our conditions only about 20% of myosin is released.
A close inspection of this signal shows that it is shifted up¢eld
by 0.05 ppm relative to the signal of free myosin.ADP.
3.4. In£uence of divalent ions on the mobility of the actin
N-terminus in actomyosin
When adding Ca2þ to a solution of actomyosin in the rigor
state no e¡ect on the N-terminal signal of actin is observed
(Fig. 5). This is di¡erent to the behavior observed in the
absence of myosin where the F-actin signal was completely
quenched after addition of calcium in millimolar concentra-
tions [2]. The addition of Mg2þ ions in millimolar concentra-
tions also has no e¡ect on the signal of the N-terminus of
F-actin.
4. Discussion
4.1. Binding of the N-terminus of actin to myosin in the strong
binding state
Since up to now no crystal structure of the actomyosin
complex has been solved, only reconstructions of the complex
Fig. 4. The signal of the trimethyl amino group in di¡erent func-
tional states of myosin S1. Spectra were recorded at 800 MHz at
288 K. a: The sample contained 32 WM rabbit myosin S1 in 2 mM
Tris^HCl, pH 7.8, 30 mM KCl, 40 WM phalloidin, 0.1 mM MgCl2,
0.2 mM EGTA, 1 mM NaN3, in 90% H2O, 10% D2O. b: Same
sample but with 40 WM actin, 2 mM ADP. c: Same sample but
with 4 mM ADP, 1 mM Na3VO4 and 15 min after starting the ex-
periment. d: Same as sample c, 2 h after starting the experiment.
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are available. Due to the inherent low resolution of these data
additional structural information is necessary for obtaining
reliable structures. Carbodiimide cross-linking of the N-termi-
nus with the cluster of lysines in the loop 626^647 indicates a
direct interaction of the negatively charged N-terminus of
actin with the positive charged loop of myosin [49]. The dele-
tion of the four N-terminal amino acids in yeast actin or their
replacement by neutral amino acids leads to signi¢cant
changes of the weak and strong binding interaction and to a
decrease of the force generation [50]. Our data show unequiv-
ocally that there is no direct stable interaction of the N-ter-
minus of Mg-F-actin with myosin in the absence and presence
of ADP since the signals of the N-terminal acetyl group of
actin is not in£uenced by binding of myosin S1 or the motor
domain of Dictyostelium discoideum. This means that in the
equilibrium there is no direct interaction between the N-ter-
minus of actin and myosin in the rigor state or in the ADP
state.
Our high-resolution data are in line with more indirect
functional evidence: blocking of residues 1^7 by antibodies
inhibits the weak binding of myosin and the actin-activated
myosin ATPase but not much the strong binding of S1
[51,52].
4.2. Binding of the N-terminus of myosin light chains to actin in
the strong binding state
In the rigor state the NMR signal of the N-terminus of light
chain LC1 of rabbit myosin is quenched. This observation has
been reported previously by several groups using LC1 from
di¡erent sources [32,39^41]. The disappearance of the signal
could be caused by an immobilization by (1) a direct interac-
tion or (2) an actin-induced structural change in myosin S1
immobilizing the light chain, e.g. by a direct interaction of the
N-terminus of the light chains with the heavy chain of S1. An
additional mechanism could be (3) an exchange broadening of
the signal when there is more than one conformational state
of myosin S1 bound to actin with di¡erent environments of
the N-terminus of the light chain. Cross-linking studies [43^
45,53] indicate mechanism 1. The observation that the much
shorter light chain LC3 is not in£uenced visibly by actin bind-
ing would also be a natural consequence from mechanism 1
but would not follow directly from the two alternative mech-
anisms.
4.3. Binding of myosin to actin in the weak binding state
A transition from the tight binding state to the weak bind-
ing state of myosin is expected when ATP or ADP.Pi is bound
at the active center of myosin. This should also be observable
experimentally in the 1H NMR spectroscopy when the envi-
ronment of NMR-observable groups is changed by a change
of actomyosin interaction. The addition of 4 mM ATP to the
actomyosin solution did not lead to an observable change in
the 1H NMR spectra (Figs. 3 and 4). Especially, the signal of
the N-acetyl group of actin and the signal of the trimethyla-
mino group of LC1 did not change. This would indicate that
in the weak binding state the N-terminus of actin is not in-
volved in an interaction and the N-terminus of LC1 is immo-
bilized (most probably by direct interaction with actin). How-
ever, it is more likely that under the experimental conditions
used part of ATP is hydrolyzed and only a small proportion
of myosin is in the ATP state which cannot be observed in the
spectra.
The ADP.VO334 complex is thought to represent a rather
stable analog to ADP.Pi bound to myosin and thus may pro-
duce an NMR-visible weak binding state. Indeed, the signals
typically observed in the spectra of free myosin S1 reappear.
This can be easily seen at the signal of the trimethylamino
group of LC1 which becomes visible again. The time course of
this event is rather slow, after 15 min the equilibrium is not
reached since the signal intensity of myosin increases with
time. After 2 h a stable equilibrium is reached which is still
unchanged after incubation of the sample for 24 h. However,
only about 20% of the signal reappears indicating either that
only this percentage of myosin occurs in an NMR-visible
ADP.VO334 state or that in this state part of the signal of
myosin.ADP.VO334 is still quenched by an interaction of
LC1 with actin. However, it is known that actin competes
with vanadate bound to myosin leading to a mixture of tightly
binding myosin.ADP and weakly binding myosin.ADP.VO334 .
If this is the case then the data indicate that in the weak
binding state LC1 is not in contact with actin. The signal of
the N-terminus of actin seems to remain unperturbed after
addition of vanadate. However, the signal-to-noise ratios ob-
tainable in these experiments were not su⁄cient to exclude a
small decrease of its amplitude.
The NMR data exclude direct interactions of the N-termi-
nus with myosin in the rigor and ADP state with a longer
lifetime and signi¢cant population but do not exclude an in-
teraction in the weak binding state. This would be in line with
the observation that only the number but not the position of
Fig. 5. The e¡ect of divalent ions in the actomyosin complex. The
samples contained 26 WM myosin S1 and 38 WM actin in 2 mM
Tris^HCl, pH 7.8, 30 mM KCl, 40 WM phalloidin, 0.1 mM MgCl2,
0.2 mM EGTA, 0.2 mM ATP, 0.010 mM TSP, 0.1 mM NaN3, 90%
H2O, 10% D2O. The sample contained additionally 5 mM CaCl2
(middle) or 5 mM MgCl2 (bottom).
FEBS 26174 7-6-02
H. Kany et al./FEBS Letters 521 (2002) 121^126124
acidic residues of actin suggested to be involved in the weak
actomyosin interaction seems to be important for the interac-
tion with myosin [54]. The actomyosin interaction can be in-
creased by addition of positively charged residues in the basic
binding loop of the motor domain of D. discoideum [55,56].
These experiments suggest that during the initial formation of
the collision complex only long-range ionic interactions be-
tween myosin and the N-terminal amino acids of F-actin oc-
cur [18,19,54,57^60]. In this case they would not be observable
by NMR spectroscopy in the present setup.
4.4. E¡ect of Ca2+ or Mg2+ ions bound to the weak a⁄nity
sites of actin
Actin contains a number of weak binding sites for divalent
cations ions with a⁄nities which range from 0.018 mM31 to
6 mM31 [61^65]. These binding sites should be at least partly
occupied in the presence of 5 mM MgCl2 or 5 mM CaCl2. In
the absence of myosin Mg2þ in millimolar concentrations had
no e¡ect on the signal of Mg-F-actin indicating that the oc-
cupation of the weak binding site(s) by magnesium does not
in£uence the mobility of the N-terminal residues. In contrast,
after addition of Ca2þ to free Mg-F-actin in millimolar con-
centrations to the sample, the N-acetyl signal of F-actin was
not visible [2] in the NMR spectra. The disappearance of the
signal was interpreted as being most probably due to the ex-
change of the Mg2þ ion by Ca2þ in the active center. Since the
typical time needed for starting an NMR measurement is
5 min, the ion exchange should have been completed after
5 min.
A di¡erent result is obtained when Mg-F-actin is decorated
with myosin. Ca2þ in millimolar concentrations does not have
any e¡ect on the mobility of the N-terminus of F-actin (Fig.
4). At 288 K even after 90 min no quenching of the actin
signal can be seen. This means that the exchange of the diva-
lent ion bound to the active center of actin is strongly delayed
by binding of myosin to actin.
The mobility of the N-terminus of actin in the actomyosin
complex is also not in£uenced by the presence of free magne-
sium in millimolar concentrations. This falsi¢es one interest-
ing idea that the interaction of the negatively charged N-ter-
minus of actin with myosin requires that a supposed weak
binding site is occupied by a divalent ion.
4.5. The function of the high-mobility element in F-actin
The question remains what the reason is for the high mo-
bility of the ¢rst half of subdomain 1. At present one can only
speculate. There is now increasing evidence that for high-af-
¢nity, controlled protein^protein interaction the interaction
sites have to have an intrinsic mobility which allows the opti-
mal mutual ¢tting of the residues located at the interface. A
rather well understood example is the Ras binding to e¡ectors
whose interfaces both show high mobility [66]. This explana-
tion is excluded by our experiments: at least in the strong
binding state there is no direct interaction of the N-terminal
acetyl of actin with myosin and most probably of the whole
high-mobility region encompassing residues 1^21.
When looking at the geometry of the high-mobility region
in F-actin one sees that it is arranged almost parallel to the
¢ber axis and that it is continued by the region of low inter-
domain stability caused by the ATP binding cleft of actin.
Another, more intriguing function of the high-mobility zone
is that the cleft region and the high-mobility region would
present elastic elements which can bu¡er tensile or torsional
forces when myosin heads are attached thus preventing the
possible destruction of the ¢ber. This may be especially im-
portant in cells other than skeletal muscle where actin is not
stabilized by a sca¡old of other proteins. The last function
could be tested easily by experiment since the more rigid
Ca2þ-F-actin should be more prone to get destroyed by asym-
metrically attacking forces than Mg2þ-F-actin.
4.6. Structural consequences
The modeling of the actomyosin complex by using the
X-ray structures of free actin and myosin for the reconstruc-
tion of the data obtained from low-angle scattering or elec-
tron microscopy is the method of choice for obtaining as good
as possible models of the complex from low-resolution data.
Our NMR results make it possible to check details of these
results and may serve as an aid in model building.
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